The IASLC Lung Cancer News (ILCN) is the IASLC's official news medium for thoracic oncology specialists around the globe. ILCN provides its international audience with timely and relevant lung cancer news on topics across specialties and interests, such as novel clinical trial design and statistics, overcoming barriers to NGS testing, tobacco control and smoking/vaping cessation, patient-driven research, patient communication and care delivery during COVID, and more. Only the IASLC—the only international association dedicated to the study of lung cancer—can bring you multidisciplinary nuanced perspectives on daily clinical conundrums and the latest novel research by the true experts in the field.
Featured
Evolving Standards of Care
Radiation Oncology
Industry News & Regulatory Approvals
Names and News
Podcasts
Press Releases
The IASLC and ILCN would like to thank AstraZeneca and Daiichi Sankyo for their support.
